Matthew Wieduwilt, Jun Yin, Oudom Kour, Rebecca Teske, Wendy Stock, Carolin Escherich, Jun J. Yang, Zhenhua Li, Ken Byrd, Kimberley Doucette, James Mangan, Scott Hall, Alice Mims, Katarzyna Jamieson, Shira Dinner, Ali Bseiso, Georgia Giordano, Caner Saygin, Geoffrey Uy, Mark Litzow, Richard Stone. "Inotuzumab ozogamicin then blinatumomab for older adults with newly diagnosed, ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Extended follow-up of alliance for clinical trials in oncology A041703 cohort 1 reveals durable remission and survival." Blood, 2025. doi:10.1182/blood-2025-444